Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dóra Sántha"'
Autor:
Bence Nagy-Mikó, Orsolya Németh-Szatmári, Réka Faragó-Mészáros, Aliz Csókási, Bence Bognár, Nóra Ördög, Barbara N. Borsos, Hajnalka Majoros, Zsuzsanna Ujfaludi, Orsolya Oláh-Németh, Aliz Nikolényi, Ágnes Dobi, Renáta Kószó, Dóra Sántha, György Lázár, Zsolt Simonka, Attila Paszt, Katalin Ormándi, Tibor Pankotai, Imre M. Boros, Zoltán Villányi, András Vörös
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 21, p 15869 (2023)
We aimed to investigate the contribution of co-translational protein aggregation to the chemotherapy resistance of tumor cells. Increased co-translational protein aggregation reflects altered translation regulation that may have the potential to buff
Externí odkaz:
https://doaj.org/article/8d99ae6f8b0c4be19e261e922f262a5a
Autor:
Bence Nagy-Mikó, Orsolya Németh-Szatmári, Réka Faragó-Mészáros, Aliz Csókási, Bence Bognár, Nóra Ördög, Barbara N. Borsos, Hajnalka Majoros, Zsuzsanna Ujfaludi, Orsolya Oláh-Németh, Aliz Nikolényi, Ágnes Dobi, Renáta Kószó, Dóra Sántha, György Lázár, Zsolt Simonka, Attila Paszt, Katalin Ormándi, Tibor Pankotai, Imre M. Boros, Zoltán Villányi, András Vörös
We aimed to investigate the contribution of co-translational protein aggregation to the chemotherapy resistance of tumor cells. Increased co-translational protein aggregation reflects altered translation regulation that may have the potential to buff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58b565ea54e71304666d0a63b023cc12
https://doi.org/10.1101/2023.01.13.523908
https://doi.org/10.1101/2023.01.13.523908
Publikováno v:
Future Oncology. 15:2083-2092
Pegfilgrastim is widely used for the prevention of chemotherapy-induced neutropenia. The development and use of biosimilar agents help to rationalize healthcare expenditure and improve access to modern therapies to all who need them. This review focu
Autor:
Márton Zsolt Enyedi, Orsolya Oláh-Németh, Bernadett Csányi, Farkas Sükösd, Alíz Nikolényi, Gyöngyi Kelemen, Zsuzsanna Kahán, László Tordai, Lajos Haracska, Sára Pólya, Ágnes Dobi, Éva Szilágyi, Dóra Sántha, Eszter Sági-Zsigmond, Erzsébet Valicsek, Katalin Priskin, Rozália Tóth, Gábor Jaksa, Lajos Pintér, Gabriella Uhercsák
Publikováno v:
Cancers
Volume 13
Issue 14
Cancers, Vol 13, Iss 3489, p 3489 (2021)
Volume 13
Issue 14
Cancers, Vol 13, Iss 3489, p 3489 (2021)
Circulating tumor DNA (ctDNA) is increasingly employed in the screening, follow-up, and monitoring of the continuously evolving tumor
however, most ctDNA assays validated for clinical use cannot maintain the right balance between sensitivity, co
however, most ctDNA assays validated for clinical use cannot maintain the right balance between sensitivity, co
Autor:
Balázs Sztanó, Zoltán Pető, Tamás Vereb, Dóra Sántha, Sándor Körmöndi, Károly Péter Sárvári, Réka Kovács
Publikováno v:
Anaerobe. 65:102241
Solobacterium moorei is a strict anaerobic gram-positive rod. It is found in the human microbiota in different parts of the body, but it also appears to be an opportunistic pathogen in some infectious processes. We describe six cases of severe infect
Autor:
Gábor Pajkos, Zsuzsanna Pápai, Dóra Sántha, Renáta Kószó, Károly Máhr, László Landherr, József Erfán, Zsuzsanna Kahán, Laszlo Budi, Erika Hitre, Judit Kocsis, Zsolt Horváth, Károly Győrfy
Publikováno v:
Pathology oncology research : POR. 23(3)
Due to the limited experience with capecitabine plus docetaxel (XT) combination in the first-line treatment of metastatic breast cancer in Hungary, the main objective of the study was to analyze the effectiveness and tolerability of XT therapy. A pro